Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The polyunsaturated fatty acids (PUFAs), arachidonic acid (AA, 20:4n-6) and docosahexaenoic acid (DHA, 22:6n-3), important second messengers in brain, are released from membrane phospholipid following receptor-mediated activation of specific phospholipase A2 (PLA2) enzymes. We developed an in vivo method in rodents using quantitative autoradiography to image PUFA incorporation into brain from plasma, and showed that their incorporation rates equal their rates of metabolic consumption by brain. Thus, quantitative imaging of unesterified plasma AA or DHA incorporation into brain can be used as a biomarker of brain PUFA metabolism and neurotransmission. We have employed our method to image and quantify effects of mood stabilizers on brain AA/DHA incorporation during neurotransmission by muscarinic M1,3,5, serotonergic 5-HT2A/2C, dopaminergic D2-like (D2, D3, D4) or glutamatergic N-methyl-D-aspartic acid (NMDA) receptors, and effects of inhibition of acetylcholinesterase, of selective serotonin and dopamine reuptake transporter inhibitors, of neuroinflammation (HIV-1 and lipopolysaccharide) and excitotoxicity, and in genetically modified rodents. The method has been extended for the use with positron emission tomography (PET), and can be employed to determine how human brain AA/DHA signaling and consumption are influenced by diet, aging, disease and genetics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Basselin, M., Kim, H.-W., Chen, M., Ma, K., Rapoport, S. I., Murphy, R. C., & Farias, S. E. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002469 · Cited by 52
Self-citationRetractedJack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · cited 2×
“…receptors on activated brain microglia, was increased in cortical but not subcortical regions in Alzheimer’s disease compared with control subjects (Cagnin et al., 2001; Versijpt et al., 2003), as was uptake of [11C]PIB (Pittsburgh compound B), a ligand for fibrillar Aβamyloid plaques (Kemppainen…”
ResultHong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000 · cited 1×
“In addition, chronic lithium treatment of the rats increased brain levels of a 17-hydroxy-DHA (Basselin et al., 2010a), a DHA metabolite that is a precursor of anti-inflammatory compounds known as docosanoids (Hong et al., 2003; Serhan, 2006).”
BackgroundPhospholipase A2 structure/function, mechanism, and signaling
Burke, J. E., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800033-jlr200 · Cited by 933
(2004) · The Lancet · doi:10.1016/s0140-6736(04)16499-4 · Cited by 892 · cited 3×
“Desensitization of AA or related signals to Donepezil but not to arecoline could explain why acetylcholinesterase inhibitors may not slow Alzheimer’s disease progression (Courtney et al., 2004; Howard et al., 2007), and suggests that muscarinic agonists may prove more effective in treating the disease if the cholinerg…”
BackgroundBrain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice
Ansorge, M. S., Zhou, M., Lira, A., Hen, R., & Gingrich, J. A. (2004) · Science · doi:10.1126/science.1101678 · Cited by 817 · cited 1×
“In this regard, transient inhibition by fluoxetine of 5-HTT function during postnatal development of mice produced depression- and anxiety-related behaviors in adulthood that mimicked the behavioral phenotype of mice lacking the 5-HTT gene (Ansorge et al., 2004; Karpova et al., 2009).”
BackgroundColangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10351 · Cited by 517 · cited 2×
“…with increased IL-1β, TNFα, GFAP protein, CD11b, activated microglia surrounding senile (neuritic) plaques, and decreased synaptophysin and drebrin, pre- and postsynaptic markers (Colangelo et al., 2002; Hoozemans et al., 2001; Kitamura et al., 1999; Rao et al., In press; Stephenson et al., 1996).”
BackgroundRao, J. S., Harry, G. J., Rapoport, S. I., & Kim, H. W. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.47 · Cited by 432 · cited 3×
“Neuroinflammation has emerged as a key player in many human psychiatric, degenerative and other brain diseases, including Alzheimer’s disease, Parkinson’s disease, HIV-1 associated dementia, and BD (Anthony and Bell, 2008; McGeer et al., 2006; Rao et al., 2010; Tansey et al., 2007; Terao et al., 2006; Zhong and Lee, 2…”
BackgroundSelf-citation
Cited by
Polyunsaturated fatty acids and their metabolites in brain function and disease
Bazinet, R. P., & Layé, S. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3820 · Cited by 1,605
Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Impaired membrane lipid homeostasis in schizophrenia
Li, M., Gao, Y., Wang, D., Hu, X., Jiang, J., Qing, Y., Yang, X., Cui, G., Wang, P., Zhang, J., et al. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac011 · Cited by 63
Dalvi, S., Nguyen, H. H., On, N., Mitchell, R. W., Aukema, H. M., Miller, D. W., & Hatch, G. M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13117 · Cited by 37
“…may, in part, explain why there is such a rapid influx of ARA into the brain upon plasma infusion with ARA as previously reported (Rapoport et al. 2001; Duncan and Bazinet 2010), and extends the observation that the uptake of ARA may be mediated, in part, by its consumption (Basselin et al. 2012).”
ResultNeuron Membrane Trafficking and Protein Kinases Involved in Autism and ADHD
Kitagishi, Y., Minami, A., Nakanishi, A., Ogura, Y., & Matsuda, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16023095 · Cited by 37
“In addition, emerging evidence suggests that ω-3 PUFAs augment the therapeutic efficacy of antidepressants and mood-stabilizers [133].”
Background
Metadata
- Authors
- Basselin, M., Ramadan, E., & Rapoport, S. I.
- Venue
- Brain Research Bulletin
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 87
- Issue
- 2-3
- Pages
- 154-171
- ISSN
- 0361-9230 (ISSN-L)
- OpenAlex
- W2048016200
- Cited by
- 43
- References
- 26
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans. https://app.cochat.ai/papers/10.1016/j.brainresbull.2011.12.001
- The paper
- Basselin, M., Ramadan, E., & Rapoport, S. I. (2012). Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans. Brain Research Bulletin. https://doi.org/10.1016/j.brainresbull.2011.12.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.